Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Let's Get Moving with Flexiseq

Flexiseq and Len Goodman want to inspire sufferers of osteoarthritis and joint wear and tear to get active.


News provided by

Flexiseq

Oct 01, 2018, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Flexiseq Osteoarthritis
Flexiseq Osteoarthritis
Youtube
Youtube

LONDON, Oct. 1, 2018 /PRNewswire-PRWeb/ -- Flexiseq, the award-winning osteoarthritis gel and former Strictly Come Dancing head judge, Len Goodman, are hoping to encourage a nation experiencing joint pain and stiffness to get moving, in a bid to combat the debilitating effects of arthritis. The #LetsGetMoving campaign is designed to educate, empower and encourage the nation to get up, get out and get moving.

A recent Arthritis Research UK survey concluded that 76% of participants said joint pain prevented them from doing the things they love. In a time when the repercussions of inactivity can lead to all manner of health related conditions, Len Goodman, star of Strictly Come Dancing and Dancing With The Stars, knows this better than anyone. His knee replacement and shoulder surgeries never put pay to this National Treasure's appetite for life and activity. And he's willing others to follow suit.

Flexiseq, the award-winning osteoarthritis gel and former Strictly Come Dancing head judge, Len Goodman, are hoping to encourage a nation experiencing joint pain and stiffness to get moving, in a bid to combat the debilitating effects of arthritis.

Post this

Len said, "Flexiseq genuinely helped me with my arthritis, which is why I was delighted to be asked to be their Ambassador. Together we're on a mission to get people moving. I know I can make a difference and be an inspiration to people suffering joint pain to get moving again. There are over 10 million people with arthritis in the UK and I want to help."

Len continues: "Of course experiencing pain everyday makes it hard, but it's so important to keep going. Don't let it get you down. You have two choices, either sit around and feel sorry for yourself, which is only going to make things worse, or get up and get moving again.

"It's all about baby steps. After my knee operation I used to go swimming a lot. Sometimes I would simply walk through the water along the lanes. Slowly but surely my joints began to move more freely, and I was back on the golf course in no time!

"It is a challenge but you can do it. I want to help people get moving again - so come on Britain, Let's Get Moving."

The #LetsGetMoving campaign will be releasing regular advice on coping with joint wear and tear, from helpful exercises, to the right things to eat, all the way through to coping with the mental and emotional impact of joint pain. Len and the Let's Get Moving campaign want to empower a nation to fight back, take control and get mobile again.

Sourcing the Nation's Let's Get Moving stories

To help inspire people who are suffering from osteoarthritis, we want to encourage the British public to share their mobility stories on Twitter or Facebook using the hashtag - #LetsGetMoving. These personal accounts will each be reviewed by Len and the Flexiseq team and the most inspiring stories will win a year's supply of Flexiseq Osteoarthritis.

Announcing the partnership, Chief Executive Officer Biresh Roy said, 'We are absolutely delighted that Len has come on board as our Flexiseq Brand Ambassador. Len's energy and drive are an inspiration to all arthritis sufferers that joint pain doesn't have to get in the way of leading a full, active and healthy life'.

Nick Baverstock, Flexiseq's Marketing Director continued, 'Flexiseq offers an effective and sustainable treatment option to osteoarthritis sufferers, particularly those who cannot take traditional painkillers. We're really excited to be working with Len as we roll out our campaigns promoting the benefits of our unique brand.'

Flexiseq and Len Goodman believe it is essential to keep the nation moving to maintain both physical and mental health. It does not matter how old you are, or how you choose to get moving, be it walking, running, swimming, cycling, whatever gets the blood flowing is essential to maintaining a healthy lifestyle.

Notes to Editors:

Below are some key statistics on osteoarthritis and joint related issues in the UK from Arthritis Research UK:

Roughly 10 million people per year seek help from their doctor for arthritis or similar related ailments.
In the UK 8.75 million have been treated for osteoarthritis. That's more than the population of New York City.
In 2015 NHS Prescription Costs Analysis showed that arthritis related conditions totalled £161 million.
97% of initial knee replacement and 91% of hip replacement surgeries are as a result of osteoarthritis**

**National Joint Registry for England, Wales and Northern Ireland (2014). 11th Annual Report. Part two including data on clinical activity online at http://www.njrreports.org.uk

About Flexiseq:

Flexiseq is a topical gel that is clinically proven to help ease the pain and stiffness associated with osteoarthritis. Unlike many topical gels for joint pain, Flexiseq is drug free so can be used long-term by patients who are sensitive to, or cannot take, traditional pain medications. Find out more by visiting:
https://flexiseq.com/pages/about

Sequessome Technology

Sequessome Technology (Seq Tech) is the driving force behind Flexiseq and changes the way we approach osteoarthritis and joint wear and tear to better improve joint movement and relieve the pain of arthritis. Flexiseq's unique, joint lubricating action is made possible by Sequessome Technology which delivers lipid ingredients into joints following topical application to the site of joint pain. Find out more by visiting: https://flexiseq.com/pages/seq-technology

SOURCE Flexiseq

Related Links

http://www.flexiseq.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.